Identification of differentially expressed miRNAs involved in vascular aging reveals pathways associated with the endocrine hormone regulation Authors: Jeongwon Jeon, Subin Jang, Ki-Soo Park, Han-Gyul Kim, Jongan Lee, Tae-Sung Hwang, Jin-Sin Koh, Jaemin Kim Published: 2024 ABSTRACT Vascular aging refers to a series of processes where the elasticity of blood vessels diminishes, leading to stiffening, and deposition of fat components on the vessel walls, causing inflammation. Cardiovascular diseases, such as stroke and hypertension, play significant roles in morbidity and mortality rates among the elderly population. In this study, the Reactive Hyperemia Index (RHI) was measured to assess vascular endothelial function and aging-induced pathogenesis of vascular diseases in Korean subjects. We aimed to identify extracellular vesicle microRNAs (EV-miRNAs) with differential abundance between groups of individuals at the ends of a continuum in vascular aging acceleration, revealing miRNAs regulating genes in endocrine hormone regulation and tumor-related pathways. We also discovered that the principal component characterizing the global miRNA expression profile is significantly associated with clinical traits including cholesterol levels. Together, these data provide a foundation for understanding the role of miRNAs as modulators of longevity and for developing age-specific epigenetic biomarkers.Supplementary InformationThe online version contains supplementary material available at 10.1007/s10522-024-10167-x. Introduction Aging induces alterations in the complex interaction among cells, organs, and biological systems. With aging, arteries undergo stiffening, and vascular endothelium experiences deterioration, hallmark features of vascular aging (van der Linden et al. 2023). Both clinical and preclinical evidence elucidates that vascular aging instigates changes in the structural and functional attributes of these vessels, culminating in the onset of cardiovascular diseases (Ghebre et al. 2016; Fajemiroye et al. 2018), a leading cause of global mortality. These cardiovascular diseases are one of the most influential factors in morbidity and mortality in the elderly population (Ungvari et al. 2018). In particular, atherosclerosis is characterized by the accumulation of cholesterol crystals and the proliferation of fibrous tissue and smooth muscle, forming atherosclerotic plaques along the arterial intima, narrowing the arterial lumen, and reducing blood flow (Libby 2021). miRNAs are small non-coding RNAs, approximately 22 nucleotides in length, which exert regulatory effects by silencing target genes post-transcriptionally (Gebert and MacRae 2019). These miRNA transcripts originate from transcribed stem-loop precursors, forming primary precursor miRNAs. Cleavage of the stem-loop structure occurs in the nucleus via the miRNA processing complex, comprising RNase III Drosha and cofactor DGCR8, yielding pre-miRNAs. Subsequently, pre-miRNAs are transported to the cytoplasm and cleaved by Dicer to generate mature miRNAs (Du and Zamore 2007). A single miRNA possesses the capability to target multiple mRNAs, thereby modulating the expression of genes involved in various functional interaction pathways. Specifically, miRNAs bind to the 3′ untranslated region of mRNAs, recognizing targets via a 2–7 nucleotide sequence at the 5′ end of the miRNA (Wang et al. 2016). miRNAs play pivotal roles in regulating numerous physiological and pathological processes. Recent research has unveiled significant correlations between miR-34a and aging, particularly in the heart, endothelial cells, and endothelial progenitor cells. Elevated levels of miR-34a expression associated with aging in vascular smooth muscle cells may lead to the downregulation of SIRT1 and the induction of SASP factors (Badi et al. 2015; Badi et al. 2018; Zuccolo et al. 2020; Raucci et al. 2021). This cascade of events could exacerbate cellular aging and inflammation, hallmark features of arterial dysfunction such as atherosclerosis (Badi et al. 2015). Regulation of miRNA levels can be achieved by administering miRNA mimics or antagonists, offering potential therapeutic avenues for various diseases. Synthetic miRNA or miRNA expression vectors are employed for miRNA upregulation, whereas chemically modified anti-sense nucleotides are utilized for miRNA downregulation, ensuring stability and specificity (Ishida and Selaru 2013; Lu and Rothenberg 2018). In aging, miR-34a, which is involved in cardiac and vascular aging, has been studied as a biomarker for reducing cardiovascular aging (Hackl et al. 2010; Ito et al. 2010; Boon et al. 2013). The inhibition of three miR-34 family members (miR-34a, -34b, and -34c) was shown to alleviate cardiac dysfunction in mice (Bernardo et al. 2012). Furthermore, miR-34c was found to be increased in the hippocampus of Alzheimer’s patients and mouse models, confirming it as an effective therapeutic target (Zovoilis et al. 2011). Taken together, these results suggest that inhibition of miR-34 family members may be a potential therapeutic target in elderly patients with dementia and heart failure. Clinical sample-based miRNA studies have helped to understand the onset and progression of age-related cardiovascular disease (de Lucia et al. 2017). In this way, identifying miRNAs that affect diseases can serve as a basis for utilizing miRNA-based therapies. Chemotherapy targeting epigenetic mechanisms associated with miRNAs is emerging as a promising disease diagnosis and treatment approach. Extracellular vesicles (EVs) are lipid bilayer-enclosed particles released by cells, encompassing various subtypes such as exosomes and microvesicles (Simeone et al. 2020; Welsh et al. 2024). EVs play a pivotal role in intercellular communication by transferring proteins, lipids, and nucleic acids, influencing gene expression in recipient cells (Burrello et al. 2019; Fu et al. 2020). Recent studies have highlighted the role of EVs as mediators in the initiation and progression of vascular damage, particularly in the context of cardiovascular diseases such as atherosclerosis, heart failure, and inflammation (Pfeifer et al. 2015; Buffolo et al. 2022; Ye et al. 2022). These studies have reported that EV-mediated miRNA delivery significantly influences protein expression and phenotypic changes in recipient cells, thereby contributing to the pathogenesis of cardiovascular diseases (Das and Halushka 2015; Pfeifer et al. 2015; Koide et al. 2023). Building on these findings, we anticipate that the EV-miRNAs identified in this study will provide valuable insights into the molecular mechanisms underlying vascular aging and may serve as potential biomarkers for future research. While many studies have broadly focused on aging (Chen et al. 2010; Smith-Vikos and Slack 2012; Kumar et al. 2017), this research specifically examines the underexplored area of vascular aging using the Reactive Hyperemia Index (RHI). The RHI, indicative of cardiovascular risk factors like atherosclerosis, was measured to assess the extent of vascular aging (Kang et al. 2018; Motozato et al. 2020). This study aimed to identify miRNAs implicated in vascular aging and elucidate the intricate genetic mechanisms underlying vascular aging. A reduced RHI signifies impaired vascular endothelial function, indicating accelerated vascular aging (Kang et al. 2018; Li et al. 2023). The rate of vascular aging varies due to diverse factors among individuals. This study utilized samples from the Namgaram Cohort, which comprises 1010 Korean individuals. Previously, we identified the germline variants and genes associated with vascular aging, further evidenced by the differential mRNA expression levels of putative causal genes in aging human primary endothelial cells (Ahn et al. 2022). Thus, this study aimed to analyze miRNAs differentially expressed between groups of individuals at the ends of a continuum in vascular aging acceleration. Unlike germline mutations, miRNAs modulate post-transcriptional processes without directly altering the gene sequence (Carthew 2006; Hudder and Novak 2008). These findings thus may offer novel insights into vascular aging, potentially informing the development of future diagnostic and therapeutic modalities. Results and discussion Subject characteristics We utilized data from the Namgaram project, which included 1010 subjects aged 50 and above, recruited from Jinju in southern Korea (Ahn et al. 2022). All participants were assessed for age-related qualitative and quantitative traits, such as age, grip strength, muscle strength score, and vascular endothelial functions. The average age of the samples is 68.8 years, with 685 females and 325 males. We previously showed by the multiple logistic regression analysis that gender and age have statistically significant effects on endothelial vascular function (RHI) (Ahn et al. 2022), with a tendency for endothelial vascular function to decline in older individuals (Fig. 1A). To analyze miRNAs differentially expressed between groups of individuals at the ends of a continuum in vascular aging acceleration, we selected six individuals in the top and bottom 10th percentiles according to RHI measurements in each age group of the 50 s and 80 s. The selected 12 individuals had RHI ranging from a minimum of 0.78 to a maximum of 3.19 and comprised 4 males and 8 females (Supplementary Table 1). The levels of miRNA expression were quantified from the exosomes of twelve samples by small RNA-sequencing technology. On average, 20 million reads were generated per individual (Supplementary Table 2).Fig. 1Clinical indicators of aging in Namgaram cohort. A Simple linear regression of age and endothelial function measurement (RHI) in the cohort of 1,010 samples. The X-axis represents age, the Y-axis represents RHI. B PCA was conducted on clinical information, from the 12 selected samples utilized in the study. PC1 accounts for 30.0% of the total variance, while PC2 accounts for 18.6%. C Overall flow chart of the study Clinical indicators of aging in Namgaram cohort. A Simple linear regression of age and endothelial function measurement (RHI) in the cohort of 1,010 samples. The X-axis represents age, the Y-axis represents RHI. B PCA was conducted on clinical information, from the 12 selected samples utilized in the study. PC1 accounts for 30.0% of the total variance, while PC2 accounts for 18.6%. C Overall flow chart of the study We performed the Principal Component Analysis (PCA) of the phenotypic data from the 40 clinical traits on twelve selected samples within the Namgaram cohort. Visualization of the PCA results using the first two PCs revealed a distinct clustering of samples based on age groups of 50 s and 80 s, underscoring the profound influence of aging on overall clinical profiles. The overall changes in clinical indicators due to aging provided a clear direction for subsequent analyses and result interpretations (Fig. 1B). Vascular aging-associated miRNAs We compared the miRNA profiles between two groups stratified by endothelial vascular function acceleration for their respective ages. Each group consisted of six individuals, with three participants in their 50 s and three in their 80 s, representing the top and bottom 10th percentiles of RHI (Fig. 1C). That is, to investigate changes in miRNA abundance due to the differential pace of vascular aging. The differential abundance analysis identified four miRNAs with significant differences (P-value < 0.05) and seven miRNAs showing trends at a more relaxed threshold (P-value < 0.1) (Table 1). Notably, all significant miRNAs were downregulated in the group with accelerated vascular aging (Fig. 2A). This finding is consistent with numerous previous studies on age-associated miRNAs, which also observed a trend of downregulation (ElSharawy et al. 2012). Subsequently, we predicted the target genes of seven miRNAs with differential abundance exceeding a relaxed significance threshold by using the ‘miRWalk’ (Lewis et al. 2003; Lewis et al. 2005; Oliveira et al. 2017; Sticht et al. 2018). We then performed gene ontology (GO) and KEGG pathway analysis on the target genes to characterize the molecular mechanism underlying vascular aging. Only the terms that reached the significance threshold of Benjamini–Hochberg P-value < 0.05 were considered.Table 1Candidate miRNAs with significant expression differences between the two groups with accelerated and decelerated vascular aging. The fold-change value, statistical significance, and associated diseases for each candidate miRNA are providedmiRNAlogFCP-valueAssociated diseasesReferenceshsa-miR-98-3p− 2.146536350.035Colorectal cancer(Yiming et al.)hsa-miR-142-3p− 2.447792240.042Non-small cell lung cancer, Colorectal cancer(Chen et al. 2017; Shang et al. 2020)hsa-miR-1260b− 2.25866690.045––hsa-miR-744-5p− 2.181935640.05Ovarian cancer, Lung adenocarcinoma(Kleemann et al. 2018; Sui et al. 2019)hsa-miR-29a-3p− 1.454135840.052––hsa-miR-30e-3p− 2.258865040.054Hepatocellular carcinoma, Cardiomyocyte Autophagy(Gramantieri et al. 2020; Su et al. 2020)hsa-miR-342-3p− 1.623717960.089––Fig. 2A Heatmap displaying the differential abundance of miRNAs associated with vascular aging between the high-RHI and low-RHI groups (P-value < 0.1). The color scale represents miRNA abundance, ranging from low (blue) to high (red). B Gene Ontology (GO) enrichment of target genes associated with vascular aging-related miRNAs. The top 20 terms meeting the Benjamini–Hochberg adjusted P-value < 0.05 are displayed. The x-axis represents enrichment scores, while the color gradient indicates enrichment significance (-log10(P-value)). C KEGG pathway enrichment analysis of target genes associated with vascular aging-related miRNAs. The top 20 pathways meeting the Benjamini–Hochberg adjusted P-value < 0.05 are shown. The x-axis represents enrichment scores, and the color gradient reflects enrichment significance (-log10(P-value)) Table 1Candidate miRNAs with significant expression differences between the two groups with accelerated and decelerated vascular aging. The fold-change value, statistical significance, and associated diseases for each candidate miRNA are providedmiRNAlogFCP-valueAssociated diseasesReferenceshsa-miR-98-3p− 2.146536350.035Colorectal cancer(Yiming et al.)hsa-miR-142-3p− 2.447792240.042Non-small cell lung cancer, Colorectal cancer(Chen et al. 2017; Shang et al. 2020)hsa-miR-1260b− 2.25866690.045––hsa-miR-744-5p− 2.181935640.05Ovarian cancer, Lung adenocarcinoma(Kleemann et al. 2018; Sui et al. 2019)hsa-miR-29a-3p− 1.454135840.052––hsa-miR-30e-3p− 2.258865040.054Hepatocellular carcinoma, Cardiomyocyte Autophagy(Gramantieri et al. 2020; Su et al. 2020)hsa-miR-342-3p− 1.623717960.089–– Candidate miRNAs with significant expression differences between the two groups with accelerated and decelerated vascular aging. The fold-change value, statistical significance, and associated diseases for each candidate miRNA are provided A Heatmap displaying the differential abundance of miRNAs associated with vascular aging between the high-RHI and low-RHI groups (P-value < 0.1). The color scale represents miRNA abundance, ranging from low (blue) to high (red). B Gene Ontology (GO) enrichment of target genes associated with vascular aging-related miRNAs. The top 20 terms meeting the Benjamini–Hochberg adjusted P-value < 0.05 are displayed. The x-axis represents enrichment scores, while the color gradient indicates enrichment significance (-log10(P-value)). C KEGG pathway enrichment analysis of target genes associated with vascular aging-related miRNAs. The top 20 pathways meeting the Benjamini–Hochberg adjusted P-value < 0.05 are shown. The x-axis represents enrichment scores, and the color gradient reflects enrichment significance (-log10(P-value)) The GO analysis revealed enrichment in terms related to transcriptional regulation, protein phosphorylation, signal transduction, cell adhesion, and angiogenesis, highlighting pathways potentially involved in vascular aging and associated cellular processes (Fig. 2B; Supplementary Table 3). Particularly, angiogenesis, the process of forming new blood vessels from existing vascular structures, significantly declines with aging (Moriya and Minamino 2017). Endothelial cells play a critical role in initiating angiogenesis and forming early vascular structures, and numerous miRNAs involved in angiogenesis are known to be expressed in these cells (Lin et al. 2016). miR-29a-3p, expressed in human endothelial cells, plays a critical role in maintaining endothelial function, with its overexpression promoting angiogenesis, while its knockdown inhibits TGFβ1-stimulated angiogenesis as demonstrated in the chicken chorioallantoic membrane assay (Zhou et al. 2023). Consistent with these findings, our study identified miR-29a-3p as one of the miRNAs associated with vascular aging, demonstrating its downregulation in the group with lower RHI levels (Fig. 2A). This may suggest that the knockdown of miR-29a-3p is closely linked not only to endothelial dysfunction and vascular aging but also to impaired angiogenic capacity. The KEGG pathway analysis revealed that the vascular aging-associated miRNAs target mRNAs involved in general aging-related pathways, such as ‘cellular senescence’ and the ‘longevity-regulating pathway’. The over-represented pathways further included ‘lipid and atherosclerosis,’ ‘insulin signaling pathway,’ ‘VEGF signaling pathway,’ ‘adrenergic signaling in cardiomyocytes’ and ‘AGE-RAGE signaling pathway in diabetic complications’ (Fig. 2C; Supplementary Table 4). Advanced Glycation End-products (AGEs) are substances formed by non-enzymatic binding of proteins or fats to sugars, accumulating in the body and impairing the functions of various tissues and organs. The Receptor for Advanced Glycation End-products (RAGE) is a receptor that binds to AGEs and induces an inflammatory response. The binding of AGEs and RAGEs causes inflammation and oxidative stress through AGE-RAGE signaling, which accelerates vascular damage (Schmidt and Stern 2000; Wendt et al. 2006; Jandeleit‐Dahm et al. 2008; Villegas-Rodríguez et al. 2016; Shao et al. 2020). Insulin is a hormone responsible for regulating blood sugar, helping cells absorb glucose and use it as energy. Changes in the insulin signaling pathway can increase the risk of atherosclerosis by inducing endothelial cell dysfunction and inflammatory responses. Insulin resistance is a condition in which cells fail to respond appropriately to insulin, which leads to hyperinsulinemia and hyperglycemia, resulting in metabolic imbalance. Insulin dysregulation leads to diabetes by failing to effectively manage blood sugar. Diabetes is characterized by chronic high blood sugar, which accelerates the accumulation of AGEs. This condition activates AGE-RAGE signaling, which increases inflammation and oxidative stress, and consequently impairs the function of vascular endothelial cells and smooth muscle cells, resulting in vascular damage (Howard et al. 1996; Nigro et al. 2006; Monnier et al. 2013). Aging can be broadly defined as the time-dependent functional decline in most living organisms, which may create a permissive environment for cancer development due to systemic or organ deterioration, such as impaired immune function (Derhovanessian et al. 2008). The enriched cancer pathways included ‘colorectal cancer’, ‘chronic myeloid leukemia’, ‘glioma’, ‘gastric cancer’, ‘breast cancer’, and ‘non-small cell lung cancer’. Other cancer-related pathways included ‘pancreatic cancer’, ‘melanoma’, and ‘thyroid cancer’, as well as ‘hepatocellular carcinoma’ (Supplementary Table 4). Cancer and aging are known to share common origins, with the accumulation of cellular damage over time being considered a fundamental cause of aging (López-Otín et al. 2013). The ErbB signaling pathway and EGFR tyrosine kinase inhibitor resistance are particularly interesting. The ErbB family of receptor tyrosine kinases (RTKs), comprising epidermal growth factor receptor (EGFR), ErbB2, ErbB3, and ErbB4, plays pivotal roles in both normal physiological processes and cancer pathogenesis. EGFR and ErbB2 mutations are prevalent in epithelial tumors and have been extensively studied in cancer development and progression. Notably, EGFR mutations are frequently observed in non-small cell lung cancer (NSCLC), particularly in Asian patients (Hynes and MacDonald 2009). Significant miRNAs and their target genes’ disease associations Certain age-related pathologies, such as atherosclerosis and inflammation, are characterized by aberrant proliferation of vascular smooth muscle cell growth and hyperactivity (Zagryazhskaya and Zhivotovsky 2014). Based on the miRNAs with differential abundance and their target genes, we investigated the molecular mechanisms networks governing the related diseases. Administration of miR-29a-3p mimics results in a marked reduction in serum levels of total cholesterol, triglycerides, and low-density lipoprotein cholesterol, while concurrently elevating HDL-C levels. Furthermore, miR-29a-3p overexpression ameliorates plaque formation in atherosclerotic mouse models (You et al. 2020). The overexpression also inhibits the proliferation, migration, and invasion of vascular smooth muscle cells induced by ox-LDL, indicating that miR-29a-3p could serve as a promising gene regulator for the therapeutic management of atherosclerosis (You et al. 2020). Hypoxia stands out as a pivotal environmental factor driving the proliferation of vascular smooth muscle cells. Hypoxia-induced miR-1260b notably enhances this proliferative response. Our findings identify GDF11 as a novel target of miR-1260b, where its downregulation disrupts Smad signaling, thus facilitating increased proliferation of vascular smooth muscle cells (Seong and Kang 2020). Additionally, miR-342-3p targets PANX2, playing a crucial role in ATP/Ca2 + signaling. This pathway induces inflammatory responses that contribute to the pathogenesis of atherosclerosis (Ray et al. 2020) (Fig. 3A).Fig. 3Schematic illustration depicting the role of microRNAs and target genes in non-small cell lung cancer and lipid metabolism. A The miRNAs, their target genes, and the biological pathways elucidated in the analysis exhibit associations with non-small cell lung cancer (NSCLC). B The significant miRNAs (miR-342-3p, miR-29-3p, miR-1260b) identified in the analysis exert regulatory control over the expression of target genes, thereby influencing the shared pathway outcome of ‘lipid and atherosclerosis’ Schematic illustration depicting the role of microRNAs and target genes in non-small cell lung cancer and lipid metabolism. A The miRNAs, their target genes, and the biological pathways elucidated in the analysis exhibit associations with non-small cell lung cancer (NSCLC). B The significant miRNAs (miR-342-3p, miR-29-3p, miR-1260b) identified in the analysis exert regulatory control over the expression of target genes, thereby influencing the shared pathway outcome of ‘lipid and atherosclerosis’ These findings suggest that vascular aging-associated miRNAs contribute to the regulation of biological pathways critical to endothelial function and vascular remodeling. For example, the GO analysis highlighted the enrichment of processes related to angiogenesis, while the KEGG pathway analysis demonstrated the enrichment of pathways such as VEGFA and TGFβ signaling, which are known to play crucial roles in angiogenesis and vascular homeostasis. Dysregulation of these pathways by miRNAs like miR-29a-3p and miR-1260b may exacerbate endothelial dysfunction and vascular aging by impairing the delicate balance required for cellular proliferation, migration, and angiogenic responses. Furthermore, miRNAs identified in this study were shown to modulate pathways shared between vascular aging and the pathogenesis of non-small cell lung cancer (Gaber et al. 2014; Zhang et al. 2019; Del Re et al. 2020). Our analysis highlights miR-342-3p as a pivotal miRNA, which exerts regulatory control over its target gene RAP2B, thereby attenuating the proliferation and invasion of NSCLC cells (Shen et al. 2020). Furthermore, the overexpression of miR-142-3p augments chemosensitivity in NSCLC by inhibiting autophagy through its target HMGB1, subsequently suppressing NSCLC by modulating the P13K pathway (Chen et al. 2017). miR-1260b targets PTPRK, facilitating the migration and invasion of NSCLC cells. Additionally, miR-1260b, regulated by YY1, targets SOCS6, thereby activating KIT signaling and influencing cell proliferation and apoptosis in NSCLC (Xu et al. 2018; Xia et al. 2019; Kim et al. 2021) (Fig. 3B). These findings suggest that miRNAs linked to NSCLC may share underlying biological mechanisms with vascular aging. The overlap of vascular aging pathways with those implicated in NSCLC highlights the broader biological relevance of these miRNAs. Among the vascular aging-associated miRNAs identified in our study, miR-98-3p has been shown to exert anti-inflammatory effects in endothelial cells by inhibiting nuclear factor-κB signaling and reducing ox-LDL uptake, thereby potentially alleviating atherosclerotic burden (Schmitz et al. 2019). Furthermore, its potential cancer-related functions have been explored, with studies highlighting its involvement in colorectal cancer. A significant inverse correlation between miR-98-3p and DCAF7 expression levels has been observed in colorectal cancer tissues, where DCAF7 is highly expressed while miR-98-3p is downregulated (Yiming et al.). The identification of miRNAs that simultaneously regulate vascular aging and cancer progression suggests a shared molecular mechanism, potentially mediated by the modulation of target genes across multiple pathways. It is important to note that miRNAs typically regulate multiple target genes rather than a single one (Zheng and Zhang 2010; Berezikov 2011). Thus, it is crucial to investigate the extensive impact of miRNAs across different biological pathways (Lin et al. 2016). Association of genome-wide miRNA expression levels with clinical indicators To provide a clearer picture regarding the effect of global miRNA levels, we examined its association with 64 clinical traits with continuous variables. First, the principal component analysis (PCA) was conducted using the genome-wide miRNA level profiles of twelve individuals, resulting in dimensionality reduction to a single representation of the global expression signature. As a result, the principal component 1 (PC1) was derived, explaining 45.34% of the variance. Of the 64 traits tested, we found that the genome-wide miRNA levels were significantly associated with the level of four clinical indicators (P < 0.05): Monocyte count, Hematocrit (Hct), Cholesterol levels, and Red Blood Cell (RBC) count (Supplementary Table 5). The principal component characterizing the global miRNA level profile that is significantly associated with cholesterol levels is of particular interest, given its recognized role in atherosclerosis development (Fig. 4). Furthermore, the analysis revealed a notable influence of Monocyte levels on miRNA levels in the samples. This observation aligns with the pathophysiological process wherein, under hypercholesterolemic conditions, monocytes target damaged vascular tissue, undergo migration, and differentiate into macrophages (Nogieć et al. 2020). These macrophages, derived from monocytes, uptake oxidized low-density lipoproteins (ox-LDL), transforming into lipid-rich foam cells and releasing proinflammatory cytokines, thereby contributing to atherogenesis (Siegel-Axel et al. 2008).Fig. 4Association of the principal component characterizing the global miRNA expression and cholesterol levels in twelve individuals. The X-axis is PC1, which represents the first principal component explaining the most variation (45.34%) of miRNA expression profiles, and the Y-axis is the cholesterol measurements. Both values were expressed as rank values through Spearman correlation Association of the principal component characterizing the global miRNA expression and cholesterol levels in twelve individuals. The X-axis is PC1, which represents the first principal component explaining the most variation (45.34%) of miRNA expression profiles, and the Y-axis is the cholesterol measurements. Both values were expressed as rank values through Spearman correlation Vascular aging can be affected by various environmental and genetic factors. Recent studies generally support the association between exposure to multiple environmental stressors (such as dietary habits, and exercise) and increased risk of cardiovascular mortality and morbidity in the population. Environmental stressors have also been associated with several preclinical changes (such as obesity and inflammation)related to cardiovascular aging, including biomarkers in the population (Ungvari et al. 2008; Santos-Parker et al. 2014; Rossman et al. 2018; Bruno et al. 2020; Lan and Wu 2022). Limitations Aging is a gradual and intricate process, often marked by subtle changes rather than dramatic, observable phenotypic shifts occurring at distinct time points (Karavidas et al. 2010). While this study provides valuable insights into miRNA profiles associated with vascular aging, several limitations must be acknowledged. First, the small sample size and the limited number of individuals in each age group reduce the statistical power of the findings. Second, although this study was intentionally designed to investigate vascular aging within a Korean population to reflect region-specific and genetic factors, the results may not be generalizable to other ethnic groups. Third, relying on endothelial vascular function measurements (RHI) as a single technique may not fully capture the complexity of vascular aging. Finally, the lack of independent validation for the identified miRNAs underscores the need for follow-up studies to confirm their roles and associations. Despite these limitations, the findings provide a critical foundation for exploring vascular aging in the context of aging research, particularly within the Korean population, and suggest that future research should include larger sample sizes and validation studies to strengthen these observations. Conclusion In this study, we identified key microRNAs exhibiting differential abundance between groups of individuals at the ends of a continuum in vascular aging acceleration. We pinpointed the miR-29 family, miR-1260b, and miR-342-3p as differentially expressed miRNAs. Further analysis predicted target genes such as PANX2, TNFRSF1A, and GDF11, and KEGG pathway analysis elucidated biological pathways implicated in vascular aging. Additionally, we explored the relationship between miRNA expression levels and clinical indices, suggesting their association with cholesterol levels and thereby deepening our understanding of the functional relevance in vascular aging. Overall, this study provides initial insights into the molecular mechanisms associated with vascular aging by identifying specific miRNAs and their potential target genes. The integration of miRNA analysis, target gene prediction, and functional enrichment highlights the possible involvement of these miRNAs in biological processes relevant to vascular aging. While the findings are based on a small cohort and require validation in larger studies, they suggest a foundational framework for further exploration of miRNAs as biomarkers. Future research is needed to confirm these associations and to better understand their role in the pathophysiology of vascular aging. Material and Methods Study population and Ethics statement The study used the Namgaram Cohort, which consists of 1,010 residents of Jinju-si, Gyeongsangnam-do, Republic of Korea. Participants completed questionnaires, provided blood samples, and underwent physical evaluations. The participants were aged 50 and above, with a mean age of 68.8 years, including 685 females and 325 males. Samples from the Namgaram Cohort encompass results from a total of 156 clinical indicators. Among these, 92 are categorical variables such as smoking status, depression diagnosis, and cancer diagnosis, while 64 are continuous variables, including cholesterol levels and the number of medications taken. Among these, we selected 12 individuals and utilized whole blood samples for the study (Supplementary Table 1). This study was approved by the Institutional Review Board of Gyeongsang National University (Approval No. GIRB-A16-Y-0012), and written informed consent was obtained from all participants. Sample Collection This cross-sectional study used data from the Namgaram cohort. The cohort consisted of a group of people living in rural communities who were aged 50 years or older, and all agreed to participate in this cohort from 2015 to 2017. All 1,010 subjects enrolled in the Namgaram cohort answered questionnaires and underwent physical examinations, blood tests, and radiographic examinations. As previously outlined, endothelial cell (EC) function was assessed using the Endo-PAT2000 device, which was applied to the index finger of each hand. The degree of reactive hyperemia was determined by calculating the ratio of the average pulse amplitude from the device signal over a 1-min period beginning 1.5 min post-cuff deflation to the average pulse amplitude over a 2.5-min period prior to cuff inflation. The RHI value was then derived by comparing the reactive hyperemia ratios between the two hands (Moerland et al. 2012). To prepare serum, blood samples were collected using a butterfly needle into 5.0 mL BD Vacutainer SST II Plus plastic serum tubes and allowed to clot at room temperature for 30 min. Subsequently, all blood samples were immediately stored at − 80 °C until centrifugation. For serum separation, the blood samples were thawed on ice and centrifuged at 16,000 g for 15 min at 4 °C. The separated serum was stored at − 80 °C until further analysis. Small RNA sequencing Exosomes were isolated from 500 µL of serum using the Exo2D™-EV isolation kit for RNA analysis (EXOSOMEplus, Seoul, Republic of Korea). RNA was then isolated using the miRNeasy Serum/Plasma Advenced Kit (217,204). A library was prepared using the SMARTer smRNA-Seq Kit to sequence small RNAs from RNA. A series of steps were performed according to the manufacturer’s protocol. First, a 3' adapter was connected to the small RNA, and then a 5' adapter was additionally connected. The RNA with the adapter connected was reverse transcribed into cDNA using SMART (Switching Mechanism at the 5' end of RNA Template) technology. This cDNA was amplified by PCR using a specific primer set, and the sequencing adapters and indexes required for the Illumina sequencing platform were added during this process. After PCR amplification, the library was purified, and the size distribution and quality of the library were confirmed. Finally, the purified library was loaded onto the Illumina platform and sequenced. Sequencing was performed on NovaSeq 6000, which secured accurate sequencing data of small RNAs. The sequencing results produced an average of 20 million reads per sample. The newly sequenced data in this study are publicly available from the European Molecular Biology Laboratory-European Bioinformatics Institute (accession no. E-MTAB-14386). miRNA quantification ‘Cutadapt’ was employed to remove adapter sequences from raw small RNA sequencing data (Martin 2011). The quality of trimmed reads was again assessed using FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/), with reads having a Phred score below 30 being excluded based on quality control results. The Homo sapiens reference genome (hg38) was downloaded from the University of California, Santa Cruz (UCSC) genome browser and indexed using Bowtie (version 1.1.2; Johns Hopkins University, Baltimore, MD). Known miRNAs with annotated matches to reference genes were quantified using miRDeep2 software (Friedländer et al. 2012), mapping to miRNA sequences from miRbase v22.1 (Kozomara et al. 2019), while novel miRNAs not matching reference genes in the database were predicted. Differential abundance analysis We conducted analysis on 80 microRNAs out of a total of 2657 microRNAs, which had count values present in at least 6 out of the 12 samples. The R package ‘edgeR’ was utilized to identify miRNAs exhibiting differential abundance (Robinson et al. 2010). miRNAs with differential abundance were filtered based on criteria of P-value < 0.1. Visualization of analysis results was facilitated using the R package ‘ggplot2’ (Wilkinson 2011). Target genes were predicted for filtered miRNAs using ‘miRWalk’ (Sticht et al. 2018). Functional Enrichment Analysis GO and KEGG pathway analyses were performed on target genes using DAVID v6.8 (https://david.ncifcrf.gov/) for functional annotation and enrichment analysis, with a significance threshold set at a Benjamini–Hochberg corrected P-value < 0.05. Pathway results meeting the significance criteria are presented in the supplementary table (Supplementary Table 3, 4). Supplementary Information Below is the link to the electronic supplementary material.Supplementary file1 (DOCX 145 KB)Supplementary file2 (XLSX 30 KB) Supplementary file1 (DOCX 145 KB) Supplementary file2 (XLSX 30 KB)